Literature DB >> 34178573

Inflammatory Pathways in Psychiatric Disorders: The case of Schizophrenia and Depression.

Tami Feng1, Ashutosh Tripathi1, Anilkumar Pillai1,2.   

Abstract

PURPOSE OF REVIEW: A better understanding of the key molecules/pathways underlying the pathophysiology of depression and schizophrenia may contribute to novel therapeutic strategies. In this review, we have discussed the recent developments on the role of inflammatory pathways in the pathogenesis of depression and schizophrenia. RECENT
FINDINGS: Inflammation is an innate immune response that can be triggered by various factors, including pathogens, stress and injury. Under normal conditions, the inflammatory responses quiet after pathogen clearance and tissue repair. However, abnormal long-term or chronic inflammation can lead to damaging effects. Accumulating evidence suggest that dysregulated inflammation is linked to the pathogenesis of neuropsychiatric disorders. In this review, we have discussed the roles of complement system, infiltration of peripheral immune cells into the central nervous system (CNS), the gut-brain axis, and the kynurenine pathway in depression and schizophrenia.
SUMMARY: There is a large body of compelling evidence on the role of inflammatory pathways in depression and schizophrenia. Although most of these findings show their roles in the pathophysiology of the above disorders, additional studies are warranted to investigate the therapeutic potential of various immune signaling targets discussed in this article.

Entities:  

Keywords:  Schizophrenia; complement system; depression; gut-brain axis and kynurenine pathway; infiltration; inflammation

Year:  2020        PMID: 34178573      PMCID: PMC8223755          DOI: 10.1007/s40473-020-00207-4

Source DB:  PubMed          Journal:  Curr Behav Neurosci Rep


  100 in total

1.  Prenatal Dynamics of Kynurenine Pathway Metabolism in Mice: Focus on Kynurenic Acid.

Authors:  Nick Goeden; Francesca M Notarangelo; Ana Pocivavsek; Sarah Beggiato; Alexandre Bonnin; Robert Schwarcz
Journal:  Dev Neurosci       Date:  2017-10-28       Impact factor: 2.984

Review 2.  The complement system in schizophrenia.

Authors:  Karine R Mayilyan; Daniel R Weinberger; Robert B Sim
Journal:  Drug News Perspect       Date:  2008-05

3.  Regulation of proinflammatory monocyte activation by the kynurenine-AhR axis underlies immunometabolic control of depressive behavior in mice.

Authors:  Xiaojie Zang; Xiao Zheng; Yuanlong Hou; Miaomiao Hu; Hong Wang; Xiaoqiang Bao; Fang Zhou; Guangji Wang; Haiping Hao
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

Review 4.  Inflammasome, Inflammation, and Tissue Homeostasis.

Authors:  Vijay A K Rathinam; Francis Ka-Ming Chan
Journal:  Trends Mol Med       Date:  2018-02-09       Impact factor: 11.951

5.  Increased cerebrospinal fluid complement C5 levels in major depressive disorder and schizophrenia.

Authors:  Takashi Ishii; Kotaro Hattori; Tomoko Miyakawa; Kentaro Watanabe; Shinsuke Hidese; Daimei Sasayama; Miho Ota; Toshiya Teraishi; Hiroaki Hori; Sumiko Yoshida; Akihiko Nunomura; Kazuyuki Nakagome; Hiroshi Kunugi
Journal:  Biochem Biophys Res Commun       Date:  2018-02-16       Impact factor: 3.575

6.  HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway.

Authors:  Bo Wang; Yong-Jie Lian; Wen-Jun Su; Wei Peng; Xin Dong; Lin-Lin Liu; Hong Gong; Ting Zhang; Chun-Lei Jiang; Yun-Xia Wang
Journal:  Brain Behav Immun       Date:  2017-11-28       Impact factor: 7.217

7.  The Metabolic Factor Kynurenic Acid of Kynurenine Pathway Predicts Major Depressive Disorder.

Authors:  Hongye Liu; Lei Ding; Huifeng Zhang; David Mellor; Haiyan Wu; Dongmei Zhao; Chuangxin Wu; Zhiguang Lin; Jiaojian Yuan; Daihui Peng
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

Review 8.  Gut microbial metabolites in depression: understanding the biochemical mechanisms.

Authors:  Giorgia Caspani; Sidney Kennedy; Jane A Foster; Jonathan Swann
Journal:  Microb Cell       Date:  2019-09-27

9.  Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation.

Authors:  Helen Q Cai; Vibeke S Catts; Maree J Webster; Cherrie Galletly; Dennis Liu; Maryanne O'Donnell; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

10.  Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice.

Authors:  Koji Ataka; Akihiro Asakawa; Kanna Nagaishi; Kaori Kaimoto; Atsushi Sawada; Yuko Hayakawa; Ryota Tatezawa; Akio Inui; Mineko Fujimiya
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more
  7 in total

Review 1.  Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry.

Authors:  David S Thylur; David R Goldsmith
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

2.  Mental Disorders Are Associated With Leukocytes Telomere Shortening Among People Who Inject Drugs.

Authors:  Mélusine Durand; Nicolas Nagot; Laurent Michel; Sao Mai Le; Huong Thi Duong; Roselyne Vallo; Amélie Vizeneux; Delphine Rapoud; Hoang Thi Giang; Catherine Quillet; Nham Thi Tuyet Thanh; Khuat Thi Hai Oanh; Vu Hai Vinh; Jonathan Feelemyer; Philippe Vande Perre; Khue Pham Minh; Didier Laureillard; Don Des Jarlais; Jean-Pierre Molès
Journal:  Front Psychiatry       Date:  2022-06-17       Impact factor: 5.435

Review 3.  Mitophagy in depression: Pathophysiology and treatment targets.

Authors:  Ashutosh Tripathi; Giselli Scaini; Tatiana Barichello; João Quevedo; Anilkumar Pillai
Journal:  Mitochondrion       Date:  2021-08-31       Impact factor: 4.160

Review 4.  Chronic cerebral aspects of long COVID, post-stroke syndromes and similar states share their pathogenesis and perispinal etanercept treatment logic.

Authors:  Ian Albert Clark
Journal:  Pharmacol Res Perspect       Date:  2022-04

5.  Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid.

Authors:  Korrapati V Sathyasaikumar; Francesca M Notarangelo; Deanna L Kelly; Laura M Rowland; Stephanie M Hare; Shuo Chen; Chen Mo; Robert W Buchanan; Robert Schwarcz
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-15

6.  C1q deletion exacerbates stress-induced learned helplessness behavior and induces neuroinflammation in mice.

Authors:  Amit Kumar Madeshiya; Carl Whitehead; Ashutosh Tripathi; Anilkumar Pillai
Journal:  Transl Psychiatry       Date:  2022-02-01       Impact factor: 7.989

7.  Old and New Biomarkers for Infection, Inflammation, and Autoimmunity in Treatment-Resistant Affective and Schizophrenic Spectrum Disorders.

Authors:  Christian Scheiber; Tanja Schulz; Julian M Schneider; Karl Bechter; E Marion Schneider
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.